Effects of Prenatal Illicit Drug. Use on Infant and Child

Similar documents
Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Understanding Prenatal Drug Exposure

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

Methadone and Pregnancy

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Outcomes of Infants with Neonatal Abstinence Syndrome

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists

Relationships Relationships

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Common Drugs of Abuse. Tobacco/Nicotine Cannabis Alcohol Opiates Cocaine Methamphetamine. 36 weeks gestation adult

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN

Brief History of Methadone Maintenance Treatment

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Substance-Exposed Newborn

Marijuana in the Obstetric Population

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Safe Babies Foster Parent Training Program

MOMS Project Panel Overview

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Substance-Exposed Newborns

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

The Opioid-Exposed Woman

Pregnancy and Epilepsy

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Marijuana Use During Pregnancy and Breastfeeding Findings Summary

Birth mother Foster carer Other

Born on Opioids 11/15/2018. Current Epidemic of Opiates. Opioid Exposed Infant. Khalid Awad, MD

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018

SUBSTANCE EXPOSED NEWBORNS

Substance-Exposed Newborns

Part 2 Who Is at Risk? What Does FASD Look Like? FASD Diagnostic Guidelines. Common Challenges Across the Spectrum

Opiate Use in Reproductive Age Females

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Introduction. Background

11/3/2014. Opiates: methadone, buprenorphine, heroin, prescription drugs: Vicodin, OxyContin, Percocet

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

When you drink, your baby drinks too. Drinking alcohol during

Opioid use in pregnancy and Neonatal Abstinence Syndrome

What To Expect. Maternal Cannabis Use during Pregnancy and the Impacts on Offspring

Marijuana During Pregnancy: An Overview

Prenatal Substance Abuse: Improving Outcomes

Response to the Language Equality and Acquisition for Deaf Kids (LEAD-K) Task Force Report

Section F: Discussing the diagnosis and developing a management plan

Neonatal Drug Withdrawal

IDENTIFICATION AND MANAGEMENT OF PERINATAL SUBSTANCE ABUSE

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT

Talking with your doctor

The Substance Exposed Newborn Alphabet Soup

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

EI Leadership April 24, 2018

Structured Guidance for Postpartum Retention in HIV Care

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

natal Marijuana and Public Health: The Colorado Perspective

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

PREGNANCY SMOKING AND CHILD OUTCOMES FROM BIRTH TO 15 MONTHS: FINDINGS FROM NORTHEAST TENNESSEE. Beth Bailey, PhD

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

UNIVERSITY OF WASHINGTON

Marijuana in Pregnancy

Drugs cross the placenta producing a new set of pharmacokinetics.

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Neonatal abstinence syndrome

Opioid Abuse Treatment in Pregnancy

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Prescription Opioids

Addiction Across the Lifespan

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

New Patient Information Form

Objectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

2/24/2014. Bridging the Gap Between Behavioral Health and Pregnancy. My Background and Interest in the Topic... Plan for Today

Methamphetamine use during pregnancy: A tale of 2 toxins!

Understanding the Impact of Drugs on Children. Jackie McReynolds Washington State University

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay

Addressing Substance Use Among Pregnant Women and New Moms

Medication for the Treatment of Addiction (MAT)

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Counseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use

Child Welfare and MOMS: Building Partnerships to Improve Care

Neonatal Abstinence: The epidemic Its Impact on All of Us

Transcription:

Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011

Objectives for Presentation At the end of this presentation, participants can describe: Prevalence of substance use and abuse in pregnancy Neonatal effects of substance use Child development effects of prenatal drug exposure What role family medicine will play in changing the outcomes Note: Pictures shown are not of families receiving services 2

NM Study of Alcohol and Drug Use at Time of Pregnancy Testing 1990-95 Use in past month (questions and UDS) in 1995 cohort Marijuana use in past month 20% Other drugs in past month 6% Methamphetamine 2.8% Cocaine 3% Opiates 0.6% Use of drugs with alcohol and tobacco Implication: 5,400 infants with drug exposure Autism risk 1 in 150 by comparison * NM Department of Health, Division of Epidemiology, 1996 3

Meconium Testing Results 2005-07 Albuquerque Area Hospitals Albuquerque Drugs National 6.84% Amphetamines 4.57% 15.59% Cocaine 10.01% 4.37% Opiates 7.01% 13.17% Cannabinoids 11.31% 1.9% Sedatives 2.03% 2.86% Methadone 4.41% 12.84% FAEE 13.29% By permission Tricore Laboratories and United States Drug Testing Laboratories, Inc 4

Critical Times for Embryo Dr Mark Hill (2007), University of New South Wales

Effects of Drugs on the Development of the Fetal Brain Brain differentiation in first 13 weeks gestation Brain grows most in last 13 weeks gestation Premature delivery adds stresses Brain injury can occur with prematurity < 37 weeks Mother s overall health affects brain size Drugs move from pregnant woman to fetus Areas of fetal brain potentially affected Effects illustrated by adult brain

Areas of Fetal Brain Affected: Example Adult Brain Exposed to Cocaine Front of adult brain 1-2 Min 3-4 5-6 6-7 7-8 8-9 Yellow areas indicate binding of cocaine to receptors in specific areas of the brain (Striatum) occurring over a defined time in an adult brain 9-10 10-20 20-30

Specific Effects Related to Drugs Ethanol causes birth defect pattern Affects brain cortex neuron development & growth Results in facial malformations Opiate drugs cause withdrawal (NAS) Opiate receptors modulate dopamine Cannabinoid receptors affect GABA, glutamate release Stimulants affect fetal circulation and placental irritability leading to premature birth Stimulants modulate synaptic dopamine levels

Anticipated Specific Issues from Prenatal Opiate Exposure Withdrawal (NAS) from opiate exposure Heroin, morphine, codeine, oxycodone Methadone 90% have symptoms needing treatment by 96 hrs Treatment with methadone is standard Carrie Tingley Pediatric unit if available (ICN3 other option) Symptoms closely monitored using scoring system Infants discharged off methadone Buprenorphine with reduced duration of symptoms

Studies of Effects of Drugs on Child and Adolescent Development No single study is perfect Best of longitudinal studies Marijuana exposed infants Hamilton, Ontario (OPPS Study) Maternal Lifestyles Study, multiple centers, and cocaine use in pregnancy Pittsburgh cohort study, Maternal Health Practices and Child Development Study (MHPCD) IDEAL Study of methamphetamine exposure All have comparison groups from birth Relatively good matching for use of other drugs such as tobacco and cocaine

Effects Seen with Marijuana Use Exposed pregnancies with same weight gain Infant weight reduced in US (2 nd trimester effect) 20+ year follow up studies OPPS and MHPCD Problems with tasks that required visual memory, analysis, and integration age 13-16 Altered processing in visual-spatial working memory age 19-20 by functional MRI Negative effects on aspects of executive function Earlier teen marijuana use in prenatally exposed

Summary of Cocaine Studies Between exposed and comparison groups Infants with exposure have: Disturbed state regulation Increased muscle tone Developmental differences lessen 3 to 7 Functional brain studies of teens in process Cohorts reaching 20 years of age Cocaine exposed have visual processing delays

Long Term Exposure Effects; Results Pending As study kids approached adolescence Stronger evidence for behavioral problems Possible tendency to start use earlier Subtle effects on brain function Visual attention on tasks lower Executive function affected Setting priorities when facing multiple tasks Demonstrate selective attention

Study of Combine Opiate and Cocaine Exposure With Home Visiting Intervention Cohort of exposed kids follow up at age 7 Began in study as newborns Home intervention first 18 mos of life Intelligence, academic performance collected Child behavior checklist Environmental conditions Comparison group enrolled at age 5 Same neighborhood, same clinic No history of drug exposure, - toxicology at birth No substance use history by self report Nair P, Black MM, et al. Ambulatory Pediatrics 2008; 8:154-61

Results of Environmental Descriptors in Longitudinal Study Caregiver IQs 81.2-81.7 (+ 12.3-10.5) low normal Kids with exposure More caregiver changes, possible loss of parents 44% lived with relative not mother Higher ongoing drug & tobacco use in home Kids in comparison group 100% with mother 92% of caregivers employed Depression present for 12-13% in caregivers Exposed kids had greater numbers of ACEs

Results of Child Testing After 18 Months of Home Visiting No statistical differences between groups Exposed had lower scores 15/16 subtests for cognition Both groups IQ scores below mean (< 95) Behavior problems not different Exposed led in 8/10 subtests behavioral problems Few significant differences from prenatal exposure Associations of lower scores and caregiver depression

Program Approaches: Effects of Home Visiting by Program at 18 Months Maternal behavior in mother-child interaction Decreased by ongoing drug use; cocaine and heroin Inhibited by poor parenting attitude Case management intervention not delivered Intervention group should have had weekly visits for 6 mos Mean was 8.9 visits (not 24), mean length 30 minutes Average contact 4.5 hours Home intervention had no overall effects Nair P, Black MM, et al. Ambulatory Pediatrics 2008; 8:154-61

Human Prenatal Exposure to Methamphetamine Should have similar effects as cocaine Concern, the 2 nd highest level of possible effect for humans Neurobehavioral alterations from prenatal exposure Methamphetamine Human studies not interpretable currently Lack of controls and confounding factors Absence of purity of drugs Potential presence of contaminants Animal studies had evidence for poor outcomes NATIONAL TOXICOLOGY PROGRAM Center for the Evaluation of Risks to Human Reproduction (NTP-CERHR) 2005 18

FOCUS Case Management FOCUS service coordinator model Starts when baby referred to program Funding from Part C for early child intervention for child Home based parenting and development Birth to 3 years (2x longer than study), weekly to monthly Addresses parent issues; safety, addiction, health Provides insight to medical team about family Not medically trained, limited access to PCO Very knowledgeable about health and life issues Present in FOCUS clinics

Case Management for Pregnant Women in Milagro Reflejos Familiares grant funded program Referrals from Milagro counselors or prenatal Not currently co-located Service coordinator assigned Challenge to engage pregnant women When engagement happens, services start, not paid for Basic needs, issues for housing, safety, older children Prepares women for parenting role After delivery service coordinator continues contact Parenting groups, infant mental health model, 12 weeks

Many Pregnant Women Use Substances Which mom will stop or reduce use? What are motivators to change? How does newborn create change? Resources to support change Counseling services accessible? Counseling services appropriate? Financial considerations? Impact of partner and family? How will better health be achieved?

The Medical Model Is Necessary But Not Sufficient to Deliver Health for These Families Change in behaviors are difficult Needs of child replace interest in drugs Different way of rebuilding dopamine system The health of the parents directly impact the children Primary care must address the physical and mental Service coordinators are the rock for most mothers

Cases for Effects of Prenatal Substance Exposure Case 1: Cheryl Wildman and baby Russ 23

Cheryl W. Delivers Baby Russ on L&D www.whattoexpect.com Had chronic pain Prescribed Percocet Took 12 to 16 per day Plans to breastfeed Mom agrees to toxicology Negative for drugs Baby has positive toxicology Positive for opiates Positive for cannabinoids

How Will You Manage Care? How to assess risk of NAS for Russ? What are plans related to breastfeeding? What counseling will you provide?

Factors Related to Mom s Social Status Cheryl s pain condition under care Mom has prescription May be using too much May access other sources Possible risk of addiction Not disclosed to prenatal provider Positive screen implications Marijuana used for nausea Hospital may refer to CYFD

Factors Related to Russ care Russ has had exposures Opiates; risk of neonatal abstinence Exposure started early in pregnancy Marijuana used regularly Observation for 96 hours Breastfeeding may be good for both Mom s first UDATR negative Discuss baby s screens Request repeat UDATR

Russ Observed in Carrie Tingley Cheryl can room in Her daily UDATRs are negative Breastfeeding established Cheryl requests buprenorphine induction Starts on 12 mg per day Breastfeeding continues Cheryl and Russ have FOCUS appointments

Renee Brings Daughter Lorena for Well Visit Renee used cocaine and marijuana prenatally Lorena born at 37 weeks, 5% for OFC Renee did well for 6 months after starting care in FOCUS She relapsed and disappeared for 9 months Made contact with service coordinator Developmental assessment done

Results of Lorena s Assessment Gross Motor age equivalent 11.5-13 mos Fine Motor - 11.5-13 mos Language/Communication - 15.5-18 mos Emotions and Feeling States - 11.5-13 mos Self-Help - 15.5-18 mos Relationship to Person 7-10 mos

How To Assess Results? How significant are the delays? What information does Renee need? What does Lorena need? What other considerations come into play?

Further Evaluation for Lorena History of sleep, growth History of behavior Growth chart for head size Examine for syndrome Examine ears for chronic OM Audiology referral for hearing sfcrime.wordpress.com Early intervention referrals FOCUS services started Community agencies

We Help a Family Become Healthier Overall hope of FOCUS Programs Goals of FOCUS Programs are to support the normal development of infants and children Thank You